Memo3 at the ISPE Pharma 4.0™ and Annex 1 Conference 2023

At the ISPE Pharma 4.0™ and Annex 1 Conference 2023, Memo3 experienced exciting days at the heart of pharmaceutical innovation. The conference provided a diverse platform where leading industry experts, technology providers and regulators discussed current trends. 

Highlights and insights 

- Pharma 4.0™ Integration: The transformative power of Pharma 4.0™ and digitization in focus, how they are changing operations, quality and maintenance in the pharma landscape.
- Annex 1 Implementation: Practical strategies to smoothly integrate the latest Annex 1 version through real-life case studies.
- Automation and Innovation: A look at the impact of automation on innovative processes, from ATMPs to gene therapy.
- Rapid monitoring and testing: Improving quality assurance through rapid microbial monitoring and optimizing supply chains. 

CEO Josef Trapl in the spotlight 

A particular highlight was CEO Josef Trapl, who led the session "Annex 1 Implementation between GxP and Cost Containment", providing valuable insights into the challenges and opportunities of Annex 1 implementation. 

Networking and looking to the future 

The conference not only offered valuable expertise, but also the opportunity to make important contacts and exchange experiences. The inspiring program motivated us to remain active in the pharmaceutical field. 

Outlook 

Attending the conference strengthened our commitment to innovation and collaboration. Stay tuned to our blog to learn more about our projects and the latest developments in the pharmaceutical industry.